天美传媒

Abstract

This project report provides a comprehensive overview of the pharmacovigilance of antifungal drugs, focusing on regulatory considerations, risk management strategies, key findings from pharmacovigilance reports and future directions in antifungal therapy. The report highlights the importance of continuous monitoring and assessment of antifungal drugs to ensure their safe and effective use. Key findings include the increased risk of gastrointestinal adverse effects, hepatotoxicity, renal impairment, allergic reactions and potential drug interactions associated with antifungal drugs. Recommendations for safe use include adherence to recommended dosages, limitation of prolonged use, awareness of potential adverse effects, individualized risk assessment and patient education. The report concludes with a call for ongoing surveillance, research and development of novel antifungal agents to address evolving challenges in antifungal therapy and ensure patient safety.

Keywords: Antifungal drugs; Pharmacovigilance; Regulatory considerations; Risk management strategies; Key findings; Future directions; Drug safety; Adverse effects; Drug interactions; Hepatotoxicity; Renal impairment; Allergic reactions